
Research and development of innovative medicines to improve and extend people's lives.
B
CSR Analysis score
The organization is among the top 20% of most committed organizations, excluding the top 5%, among comparable organizations.
+160,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: December 2025
This analysis is not yet available in English. Please see the French version.
Leading organizations
ipbs-toulouse (cnrs-ut3)
B
Research and development in cancer, infection, and inflammation to improve therapeutics.
Danone Research & Innovation
B
Research and development of innovative nutritional solutions to improve health and well-being.
Amgen France
B
Research, development, and manufacturing of innovative therapies for serious diseases using biotechnology.
Initiatives identified among leaders
mesures pour réduire les émissions de gaz à effet de serre en France
“Amgen prend des mesures pour réduire les émissions...” - Amgen FranceDéveloppement de solutions nutritionnelles pour les consommateurs et les patients
“Danone Research & Innovation développe des solutio...” - Danone Research & InnovationCréation d'un environnement de travail favorable
“Amgen s.a.s. crée un environnement de travail favo...” - Amgen France53% of similar organizations communicate on CSR issues
+3090 initiatives collected from 100 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports